cholecystectomy and glp 1 Mounjaro, Wegovy & Gallstones: Surgical Guide GLP-1 Use After Gallbladder Removal:

Thus, for a given secondary outcome, patients were not censored if they had another event that was part of the composite outcome (other than suicide)

Obesity is a wellestablished risk factor for AFib and is associated with poorer outcomes following catheter ablation

Participants on the highest dose (15 mg) achieved an average weight reduction of 22.9% over three years, marking one of the longest documented sustained weight loss effects in obesity pharmacotherapy

2026 Mochi Health

For example, a major study in the New England Journal of Medicine found that weekly injectable semaglutide helped adults lose nearly 15% of their body weight over 68 weeks

Mazdutide, also known as IBI362, is an investigational peptide drug developed by Innovent Biologics for the treatment of obesity and metabolic diseases